Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery
Latest Information Update: 14 Jun 2024
At a glance
- Drugs NEO-PV 01 (Primary) ; Poly ICLC (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- 11 Jun 2024 Status changed from active, no longer recruiting to recruiting.
- 25 Mar 2024 Status changed from recruiting to active, no longer recruiting.
- 11 Oct 2022 Status changed from not yet recruiting to recruiting.